Open sidebar
Focus
Guillain-Barré syndrome
COVID Vaccines
|
Ellen Wan
Certain COVID-19 Vaccines Linked to Elevated Risk of Guillain-Barré Syndrome
As the rate of vaccination increases so has the incidence of GBS—particularly after viral vector-based vaccines such as AstraZeneca.
Nov 09, 2023
|
Ellen Wan
Nov 09
|
Frontline Health
|
Dan Skorbach
Rare Disease Erupts in Peru; WHO to Authenticate Health Records; Surprising Habits That Damage Liver
Jul 22, 2023
|
Dan Skorbach
Jul 22
|
COVID News
|
Zachary Stieber
Guillain-Barré Syndrome Linked to COVID-19 Vaccine: CDC Study
Feb 03, 2023
|
Zachary Stieber
Feb 03
|
Canada
|
Lee Harding
COVID Vax Compensation Recipient ‘Disheartened’ Over Lack of Recognition of the Vaccine Injured
Jun 03, 2022
|
Lee Harding
Jun 03
|
Vaccines & Safety
|
Marina Zhang
‘Significant’ Cases of Neurological Disorder Associated With the AstraZeneca Vaccine
May 31, 2022
|
Marina Zhang
May 31
|
Vaccines & Safety
|
Jack Phillips
Rare Nerve Disorder Listed as COVID-19 Vaccine Side Effect by EU
Sep 08, 2021
|
Jack Phillips
Sep 08
|
COVID Vaccines
|
Meiling Lee
Benefits of Johnson & Johnson COVID-19 Vaccine ‘Continue to Outweigh’ the Risk of Neurological Disorder: CDC Advisory Panel
Jul 22, 2021
|
Meiling Lee
Jul 22
|